TARGETING HER2 IN EARLY BREAST CANCER FROM THE STANDARD TO A NEW THERAPEUTIC STRATEGY

Id Provider: 1080

Evento n° 337645  

Data inizio: 10/01/2022

Data fine:    31/12/2022           

Crediti assegnati: 1

Corso gratuito

https://fad.scientificorganizingservice.com/